Skip to main content
Erschienen in: Medical Oncology 5/2021

01.05.2021 | Review Article

Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?

verfasst von: Precilla S Daisy, T. S. Anitha

Erschienen in: Medical Oncology | Ausgabe 5/2021

Einloggen, um Zugang zu erhalten

Abstract

Gliomas are one of the most devastating primary brain tumors which impose significant management challenges to the clinicians. The aggressive behaviour of gliomas is mainly attributed to their rapid proliferation, unravelled genomics and the blood–brain barrier which protects the tumor cells from chemotherapeutic regimens. Suspects of brain tumors are usually assessed by magnetic resonance imaging and computed tomography. These images allow surgeons to decide on the tumor grading, intra-operative pathology, feasibility of surgery, and treatment planning. All these data are compiled manually by physicians, wherein it takes time for the validation of results and concluding the treatment modality. In this context, the arrival of artificial intelligence in this era of personalized medicine, has proven promising performance in the diagnosis and management of gliomas. Starting from grading prediction till outcome evaluation, artificial intelligence-based forefronts have revolutionized oncological research. Interestingly, this approach has also been able to precisely differentiate tumor lesion from healthy tissues. However, till date, their utility in neuro-oncological field remains limited due to the issues pertaining to their reliability and transparency. Hence, to shed novel insights on the “clinical utility of this novel approach on glioma management” and to reveal “the black-boxes that have to be solved for fruitful application of artificial intelligence in neuro-oncology research”, we provide in this review, a succinct description of the potential gear of artificial intelligence-based avenues in glioma treatment and the barriers that impede their rapid implementation in neuro-oncology.
Literatur
1.
Zurück zum Zitat Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18:3–9.PubMedPubMedCentral Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev. 2017;18:3–9.PubMedPubMedCentral
2.
Zurück zum Zitat Vigneswaran K, Neill S, Hadjipanayis CG. Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification. Ann Transl Med. 2015;3:95.PubMedPubMedCentral Vigneswaran K, Neill S, Hadjipanayis CG. Beyond the World Health Organization grading of infiltrating gliomas: advances in the molecular genetics of glioma classification. Ann Transl Med. 2015;3:95.PubMedPubMedCentral
3.
Zurück zum Zitat Harder BG, Blomquist MR, Wang J, Kim AJ, Woodworth GF, Winkles JA, et al. Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma. Front Oncol. 2018;8:462.PubMedPubMedCentral Harder BG, Blomquist MR, Wang J, Kim AJ, Woodworth GF, Winkles JA, et al. Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma. Front Oncol. 2018;8:462.PubMedPubMedCentral
6.
Zurück zum Zitat Hamilton JG, Genoff Garzon M, Westerman JS, Shuk E, Hay JL, Walters C, et al. “A Tool, Not a Crutch”: patient perspectives about IBM Watson for Oncology trained by Memorial Sloan Kettering. JOP. 2019;15:e277–88.PubMed Hamilton JG, Genoff Garzon M, Westerman JS, Shuk E, Hay JL, Walters C, et al. “A Tool, Not a Crutch”: patient perspectives about IBM Watson for Oncology trained by Memorial Sloan Kettering. JOP. 2019;15:e277–88.PubMed
7.
Zurück zum Zitat Choi YI, Chung J, Kim KO, Kwon KA, Kim YJ, Park DK, et al. Concordance rate between clinicians and Watson for oncology among patients with advanced gastric cancer: early, real-world experience in Korea. Can J Gastroenterol Hepatol. 2019;2019:8072928.PubMedPubMedCentral Choi YI, Chung J, Kim KO, Kwon KA, Kim YJ, Park DK, et al. Concordance rate between clinicians and Watson for oncology among patients with advanced gastric cancer: early, real-world experience in Korea. Can J Gastroenterol Hepatol. 2019;2019:8072928.PubMedPubMedCentral
9.
Zurück zum Zitat Shahid N, Rappon T, Berta W. Applications of artificial neural networks in health care organizational decision-making: a scoping review. PLoS ONE. 2019;14:e0212356.PubMedPubMedCentral Shahid N, Rappon T, Berta W. Applications of artificial neural networks in health care organizational decision-making: a scoping review. PLoS ONE. 2019;14:e0212356.PubMedPubMedCentral
10.
Zurück zum Zitat Choy G, Khalilzadeh O, Michalski M, Do S, Samir AE, Pianykh OS, et al. Current applications and future impact of machine learning in radiology. Radiology. 2018;288:318–28.PubMedPubMedCentral Choy G, Khalilzadeh O, Michalski M, Do S, Samir AE, Pianykh OS, et al. Current applications and future impact of machine learning in radiology. Radiology. 2018;288:318–28.PubMedPubMedCentral
11.
Zurück zum Zitat Yamashita R, Nishio M, Do RKG, Togashi K. Convolutional neural networks: an overview and application in radiology. Insights Imaging. 2018;9:611–29.PubMedPubMedCentral Yamashita R, Nishio M, Do RKG, Togashi K. Convolutional neural networks: an overview and application in radiology. Insights Imaging. 2018;9:611–29.PubMedPubMedCentral
14.
Zurück zum Zitat Sikchi SS, Sikchi S, Ali MS. Artificial intelligence in medical diagnosis. Int J Appl Eng Res. 2012;7:1539–43. Sikchi SS, Sikchi S, Ali MS. Artificial intelligence in medical diagnosis. Int J Appl Eng Res. 2012;7:1539–43.
15.
Zurück zum Zitat Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol Sci. 2019;40:577–91.PubMed Harrer S, Shah P, Antony B, Hu J. Artificial intelligence for clinical trial design. Trends Pharmacol Sci. 2019;40:577–91.PubMed
17.
Zurück zum Zitat Wirtz BW, Weyerer JC. Artificial intelligence in the public sector. In: Farazmand A, editor. Global encyclopedia of public administration, public policy, and governance [Internet]. Cham: Springer International Publishing; 2019 [cited 2020 Nov 14]. p. 1–7. Available from: https://doi.org/10.1007/978-3-319-31816-5_3701-1. Wirtz BW, Weyerer JC. Artificial intelligence in the public sector. In: Farazmand A, editor. Global encyclopedia of public administration, public policy, and governance [Internet]. Cham: Springer International Publishing; 2019 [cited 2020 Nov 14]. p. 1–7. Available from: https://​doi.​org/​10.​1007/​978-3-319-31816-5_​3701-1.
18.
Zurück zum Zitat Kersting K. Machine learning and artificial intelligence: two fellow travelers on the quest for intelligent behavior in machines. Front Big Data. 2018;1:6.PubMedPubMedCentral Kersting K. Machine learning and artificial intelligence: two fellow travelers on the quest for intelligent behavior in machines. Front Big Data. 2018;1:6.PubMedPubMedCentral
20.
Zurück zum Zitat McBee MP, Awan OA, Colucci AT, Ghobadi CW, Kadom N, Kansagra AP, et al. Deep learning in radiology. Acad Radiol. 2018;25:1472–80.PubMed McBee MP, Awan OA, Colucci AT, Ghobadi CW, Kadom N, Kansagra AP, et al. Deep learning in radiology. Acad Radiol. 2018;25:1472–80.PubMed
25.
Zurück zum Zitat Lee E-J, Kim Y-H, Kim N, Kang D-W. Deep into the brain: artificial intelligence in stroke imaging. J Stroke. 2017;19:277–85.PubMedPubMedCentral Lee E-J, Kim Y-H, Kim N, Kang D-W. Deep into the brain: artificial intelligence in stroke imaging. J Stroke. 2017;19:277–85.PubMedPubMedCentral
26.
Zurück zum Zitat Ghorbanzadeh O, Blaschke T, Gholamnia K, Meena SR, Tiede D, Aryal J. Evaluation of different machine learning methods and deep-learning convolutional neural networks for landslide detection. Remote Sens. 2019;11:196. Ghorbanzadeh O, Blaschke T, Gholamnia K, Meena SR, Tiede D, Aryal J. Evaluation of different machine learning methods and deep-learning convolutional neural networks for landslide detection. Remote Sens. 2019;11:196.
27.
Zurück zum Zitat Fakoor R, Ladhak F, Nazi A, Huber M. Using deep learning to enhance cancer diagnosis and classification. In: Proceedings of the ICML Workshop on the Role of Machine Learning in Transforming Healthcare. 2013. Fakoor R, Ladhak F, Nazi A, Huber M. Using deep learning to enhance cancer diagnosis and classification. In: Proceedings of the ICML Workshop on the Role of Machine Learning in Transforming Healthcare. 2013.
28.
Zurück zum Zitat Azer SA. Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: a systematic review. World J Gastrointest Oncol. 2019;11:1218–30.PubMedPubMedCentral Azer SA. Deep learning with convolutional neural networks for identification of liver masses and hepatocellular carcinoma: a systematic review. World J Gastrointest Oncol. 2019;11:1218–30.PubMedPubMedCentral
33.
Zurück zum Zitat Davenport TH, Glaser J. Just-in-time delivery comes to knowledge management. Harv Bus Rev. 2002;80(107–11):126. Davenport TH, Glaser J. Just-in-time delivery comes to knowledge management. Harv Bus Rev. 2002;80(107–11):126.
34.
Zurück zum Zitat Zanagnolo V, Garbi A, Achilarre MT, Minig L. Robot-assisted surgery in gynecologic cancers. J Minim Invasive Gynecol. 2017;24:379–96.PubMed Zanagnolo V, Garbi A, Achilarre MT, Minig L. Robot-assisted surgery in gynecologic cancers. J Minim Invasive Gynecol. 2017;24:379–96.PubMed
35.
Zurück zum Zitat Kalantari F, Rajaeih S, Daneshvar A, Karbasi Z, Mahdi Salem M. Robotic surgery of head and neck cancers, a narrative review. Eur J Transl Myol. 2020;30:8727.PubMedPubMedCentral Kalantari F, Rajaeih S, Daneshvar A, Karbasi Z, Mahdi Salem M. Robotic surgery of head and neck cancers, a narrative review. Eur J Transl Myol. 2020;30:8727.PubMedPubMedCentral
36.
Zurück zum Zitat Zorn KC, Gofrit ON, Steinberg GD, Shalhav AL. Evolution of robotic surgery in the treatment of localized prostate cancer. Curr Treat Options Oncol. 2007;8:197–210.PubMed Zorn KC, Gofrit ON, Steinberg GD, Shalhav AL. Evolution of robotic surgery in the treatment of localized prostate cancer. Curr Treat Options Oncol. 2007;8:197–210.PubMed
37.
Zurück zum Zitat Obuchowski NA, Bullen JA. Statistical considerations for testing an AI algorithm used for prescreening lung CT images. Contemp Clin Trials Commun. 2019;16:100434.PubMedPubMedCentral Obuchowski NA, Bullen JA. Statistical considerations for testing an AI algorithm used for prescreening lung CT images. Contemp Clin Trials Commun. 2019;16:100434.PubMedPubMedCentral
38.
Zurück zum Zitat Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4:627–35.PubMedPubMedCentral Hajian-Tilaki K. Receiver operating characteristic (ROC) curve analysis for medical diagnostic test evaluation. Caspian J Intern Med. 2013;4:627–35.PubMedPubMedCentral
39.
Zurück zum Zitat Wang Z, Wang E, Zhu Y. Image segmentation evaluation: a survey of methods. Artif Intell Rev. 2020;53:5637–74. Wang Z, Wang E, Zhu Y. Image segmentation evaluation: a survey of methods. Artif Intell Rev. 2020;53:5637–74.
41.
Zurück zum Zitat Zhou N, Zhang C, Lv H, Hao C, Li T, Zhu J, et al. Concordance study between IBM Watson for oncology and clinical practice for patients with cancer in China. Oncologist. 2019;24:812–9.PubMed Zhou N, Zhang C, Lv H, Hao C, Li T, Zhu J, et al. Concordance study between IBM Watson for oncology and clinical practice for patients with cancer in China. Oncologist. 2019;24:812–9.PubMed
43.
Zurück zum Zitat Rysavy M. Evidence-based medicine: a science of uncertainty and an art of probability. AMA J Ethics. 2013;15:4–8. Rysavy M. Evidence-based medicine: a science of uncertainty and an art of probability. AMA J Ethics. 2013;15:4–8.
46.
Zurück zum Zitat Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108:479–85.PubMedPubMedCentral Fisher R, Pusztai L, Swanton C. Cancer heterogeneity: implications for targeted therapeutics. Br J Cancer. 2013;108:479–85.PubMedPubMedCentral
48.
Zurück zum Zitat Rudie JD, Rauschecker AM, Bryan RN, Davatzikos C, Mohan S. Emerging applications of artificial intelligence in neuro-oncology. Radiology. 2019;290:607–18.PubMedPubMedCentral Rudie JD, Rauschecker AM, Bryan RN, Davatzikos C, Mohan S. Emerging applications of artificial intelligence in neuro-oncology. Radiology. 2019;290:607–18.PubMedPubMedCentral
49.
Zurück zum Zitat Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol. 2003;30:4–9.PubMed Brandes AA. State-of-the-art treatment of high-grade brain tumors. Semin Oncol. 2003;30:4–9.PubMed
50.
Zurück zum Zitat Alieva M, van Rheenen J, Broekman MLD. Potential impact of invasive surgical procedures on primary tumor growth and metastasis. Clin Exp Metastasis. 2018;35:319–31.PubMedPubMedCentral Alieva M, van Rheenen J, Broekman MLD. Potential impact of invasive surgical procedures on primary tumor growth and metastasis. Clin Exp Metastasis. 2018;35:319–31.PubMedPubMedCentral
51.
Zurück zum Zitat Kong K, Rowlands CJ, Varma S, Perkins W, Leach IH, Koloydenko AA, et al. Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy. Proc Natl Acad Sci USA. 2013;110:15189–94.PubMed Kong K, Rowlands CJ, Varma S, Perkins W, Leach IH, Koloydenko AA, et al. Diagnosis of tumors during tissue-conserving surgery with integrated autofluorescence and Raman scattering microscopy. Proc Natl Acad Sci USA. 2013;110:15189–94.PubMed
54.
Zurück zum Zitat Wu C-C, Guo W-Y, Chen M-H, Ho DMT, Hung ASC, Chung H-W. Direct measurement of the signal intensity of diffusion-weighted magnetic resonance imaging for preoperative grading and treatment guidance for brain gliomas. J Chin Med Assoc. 2012;75:581–8.PubMed Wu C-C, Guo W-Y, Chen M-H, Ho DMT, Hung ASC, Chung H-W. Direct measurement of the signal intensity of diffusion-weighted magnetic resonance imaging for preoperative grading and treatment guidance for brain gliomas. J Chin Med Assoc. 2012;75:581–8.PubMed
55.
Zurück zum Zitat Li-Chun Hsieh K, Chen C-Y, Lo C-M. Quantitative glioma grading using transformed gray-scale invariant textures of MRI. Comput Biol Med. 2017;83:9283480. Li-Chun Hsieh K, Chen C-Y, Lo C-M. Quantitative glioma grading using transformed gray-scale invariant textures of MRI. Comput Biol Med. 2017;83:9283480.
56.
Zurück zum Zitat Wen PY, Huse JT. 2016 World Health Organization classification of central nervous system tumors. CONTINUUM. 2017;23:1531.PubMed Wen PY, Huse JT. 2016 World Health Organization classification of central nervous system tumors. CONTINUUM. 2017;23:1531.PubMed
57.
Zurück zum Zitat Tian Q, Yan L-F, Zhang X, Zhang X, Hu Y-C, Han Y, et al. Radiomics strategy for glioma grading using texture features from multiparametric MRI. J Magn Reson Imaging. 2018;48:1518–28.PubMed Tian Q, Yan L-F, Zhang X, Zhang X, Hu Y-C, Han Y, et al. Radiomics strategy for glioma grading using texture features from multiparametric MRI. J Magn Reson Imaging. 2018;48:1518–28.PubMed
58.
Zurück zum Zitat Mao Y, Liao W, Cao D, Zhao L, Wu X, Kong L, et al. An artificial neural network model for glioma grading using image information. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:1315–22.PubMed Mao Y, Liao W, Cao D, Zhao L, Wu X, Kong L, et al. An artificial neural network model for glioma grading using image information. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:1315–22.PubMed
59.
Zurück zum Zitat Ranjith G, Parvathy R, Vikas V, Chandrasekharan K, Nair S. Machine learning methods for the classification of gliomas: initial results using features extracted from MR spectroscopy. Neuroradiol J. 2015;28:106–11.PubMedPubMedCentral Ranjith G, Parvathy R, Vikas V, Chandrasekharan K, Nair S. Machine learning methods for the classification of gliomas: initial results using features extracted from MR spectroscopy. Neuroradiol J. 2015;28:106–11.PubMedPubMedCentral
60.
Zurück zum Zitat Zhang X, Yan L-F, Hu Y-C, Li G, Yang Y, Han Y, et al. Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features. Oncotarget. 2017;8:47816–30.PubMedPubMedCentral Zhang X, Yan L-F, Hu Y-C, Li G, Yang Y, Han Y, et al. Optimizing a machine learning based glioma grading system using multi-parametric MRI histogram and texture features. Oncotarget. 2017;8:47816–30.PubMedPubMedCentral
61.
Zurück zum Zitat Brat D, Prayson R, Ryken T, Olson J. Diagnosis of malignant glioma: role of neuropathology. J Neurooncol. 2008;89:287–311.PubMed Brat D, Prayson R, Ryken T, Olson J. Diagnosis of malignant glioma: role of neuropathology. J Neurooncol. 2008;89:287–311.PubMed
62.
Zurück zum Zitat Sonoda Y, Shibahara I, Kawaguchi T, Saito R, Kanamori M, Watanabe M, et al. Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol. 2015;32:99–104.PubMed Sonoda Y, Shibahara I, Kawaguchi T, Saito R, Kanamori M, Watanabe M, et al. Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol. 2015;32:99–104.PubMed
63.
Zurück zum Zitat Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol. 2019;30:1265–78.PubMedPubMedCentral Kristensen BW, Priesterbach-Ackley LP, Petersen JK, Wesseling P. Molecular pathology of tumors of the central nervous system. Ann Oncol. 2019;30:1265–78.PubMedPubMedCentral
64.
Zurück zum Zitat Modrek AS, Golub D, Khan T, Bready D, Prado J, Bowman C, et al. Low-grade astrocytoma mutations in IDH1, P53 and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Rep. 2017;21:1267–80.PubMedPubMedCentral Modrek AS, Golub D, Khan T, Bready D, Prado J, Bowman C, et al. Low-grade astrocytoma mutations in IDH1, P53 and ATRX cooperate to block differentiation of human neural stem cells via repression of SOX2. Cell Rep. 2017;21:1267–80.PubMedPubMedCentral
65.
Zurück zum Zitat Wu S, Meng J, Yu Q, Li P, Fu S. Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas. J Cancer Res Clin Oncol. 2019;145:543–50.PubMedPubMedCentral Wu S, Meng J, Yu Q, Li P, Fu S. Radiomics-based machine learning methods for isocitrate dehydrogenase genotype prediction of diffuse gliomas. J Cancer Res Clin Oncol. 2019;145:543–50.PubMedPubMedCentral
66.
Zurück zum Zitat Zhang B, Chang K, Ramkissoon S, Tanguturi S, Bi WL, Reardon DA, et al. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro Oncol. 2017;19:109–17.PubMed Zhang B, Chang K, Ramkissoon S, Tanguturi S, Bi WL, Reardon DA, et al. Multimodal MRI features predict isocitrate dehydrogenase genotype in high-grade gliomas. Neuro Oncol. 2017;19:109–17.PubMed
67.
Zurück zum Zitat Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ. Residual deep convolutional neural network predicts MGMT methylation status. J Digit Imaging. 2017;30:622–8.PubMedPubMedCentral Korfiatis P, Kline TL, Lachance DH, Parney IF, Buckner JC, Erickson BJ. Residual deep convolutional neural network predicts MGMT methylation status. J Digit Imaging. 2017;30:622–8.PubMedPubMedCentral
68.
Zurück zum Zitat Han L, Kamdar MR. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks. Pac Symp Biocompt. 2018; 23: 331–42. Available from: https://www.worldscientific.com/doi/abs/https://doi.org/10.1142/9789813235533_0031. Han L, Kamdar MR. MRI to MGMT: predicting methylation status in glioblastoma patients using convolutional recurrent neural networks. Pac Symp Biocompt. 2018; 23: 331–42. Available from: https://​www.​worldscientific.​com/​doi/​abs/​https://​doi.​org/​10.​1142/​9789813235533_​0031.
69.
Zurück zum Zitat Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom KW, et al. Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol. 2018;39:208–16.PubMed Zhou M, Scott J, Chaudhury B, Hall L, Goldgof D, Yeom KW, et al. Radiomics in brain tumor: image assessment, quantitative feature descriptors, and machine-learning approaches. Am J Neuroradiol. 2018;39:208–16.PubMed
70.
Zurück zum Zitat Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, et al. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Am J Surg Pathol. 2006;30:828–37.PubMed Scheie D, Andresen PA, Cvancarova M, Bø AS, Helseth E, Skullerud K, et al. Fluorescence in situ hybridization (FISH) on touch preparations: a reliable method for detecting loss of heterozygosity at 1p and 19q in oligodendroglial tumors. Am J Surg Pathol. 2006;30:828–37.PubMed
71.
Zurück zum Zitat Parsons DW, Jones S, Zhang X, Lin JC–H, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807–12.PubMedPubMedCentral Parsons DW, Jones S, Zhang X, Lin JC–H, Leary RJ, Angenendt P, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008;321:1807–12.PubMedPubMedCentral
72.
Zurück zum Zitat Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765–73.PubMedPubMedCentral Yan H, Parsons DW, Jin G, McLendon R, Rasheed BA, Yuan W, et al. IDH1 and IDH2 mutations in gliomas. N Engl J Med. 2009;360:765–73.PubMedPubMedCentral
73.
Zurück zum Zitat Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, et al. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F] FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol. 2012;14:1473–80.PubMedPubMedCentral Jansen NL, Schwartz C, Graute V, Eigenbrod S, Lutz J, Egensperger R, et al. Prediction of oligodendroglial histology and LOH 1p/19q using dynamic [18F] FET-PET imaging in intracranial WHO grade II and III gliomas. Neuro Oncol. 2012;14:1473–80.PubMedPubMedCentral
74.
Zurück zum Zitat Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol. 2010;120:707–18.PubMed Hartmann C, Hentschel B, Wick W, Capper D, Felsberg J, Simon M, et al. Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas. Acta Neuropathol. 2010;120:707–18.PubMed
75.
Zurück zum Zitat Fellah S, Caudal D, Paula AMD, Dory-Lautrec P, Figarella-Branger D, Chinot O, et al. Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis? Am J Neuroradiol. 2013;34:1326–33.PubMed Fellah S, Caudal D, Paula AMD, Dory-Lautrec P, Figarella-Branger D, Chinot O, et al. Multimodal MR imaging (diffusion, perfusion, and spectroscopy): is it possible to distinguish oligodendroglial tumor grade and 1p/19q codeletion in the pretherapeutic diagnosis? Am J Neuroradiol. 2013;34:1326–33.PubMed
76.
Zurück zum Zitat Bourdillon P, Hlaihel C, Guyotat J, Guillotton L, Honnorat J, Ducray F, et al. Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status. J Neurooncol. 2015;122:529–37.PubMed Bourdillon P, Hlaihel C, Guyotat J, Guillotton L, Honnorat J, Ducray F, et al. Prediction of anaplastic transformation in low-grade oligodendrogliomas based on magnetic resonance spectroscopy and 1p/19q codeletion status. J Neurooncol. 2015;122:529–37.PubMed
77.
Zurück zum Zitat Iwadate Y, Shinozaki N, Matsutani T, Uchino Y, Saeki N. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. J Neurol Neurosurg Psychiatry. 2016;87:1016–21.PubMedPubMedCentral Iwadate Y, Shinozaki N, Matsutani T, Uchino Y, Saeki N. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. J Neurol Neurosurg Psychiatry. 2016;87:1016–21.PubMedPubMedCentral
78.
Zurück zum Zitat Hu N, Richards R, Jensen R. Role of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas: a systematic review and meta-analysis. Interdiscip Neurosurg. 2016;5:58–63. Hu N, Richards R, Jensen R. Role of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas: a systematic review and meta-analysis. Interdiscip Neurosurg. 2016;5:58–63.
79.
Zurück zum Zitat Akkus Z, Ali I, Sedlář J, Agrawal JP, Parney IF, Giannini C, et al. Predicting deletion of chromosomal arms 1p/19q in low-grade gliomas from MR images using machine intelligence. J Digit Imaging. 2017;30:469–76.PubMedPubMedCentral Akkus Z, Ali I, Sedlář J, Agrawal JP, Parney IF, Giannini C, et al. Predicting deletion of chromosomal arms 1p/19q in low-grade gliomas from MR images using machine intelligence. J Digit Imaging. 2017;30:469–76.PubMedPubMedCentral
80.
Zurück zum Zitat Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. Am J Neuroradiol. 2018;39:1201–7.PubMed Chang P, Grinband J, Weinberg BD, Bardis M, Khy M, Cadena G, et al. Deep-learning convolutional neural networks accurately classify genetic mutations in gliomas. Am J Neuroradiol. 2018;39:1201–7.PubMed
81.
Zurück zum Zitat Liu J, Chen F, Pan C, Zhu M, Zhang X, Zhang L, et al. A cascaded deep convolutional neural network for joint segmentation and genotype prediction of brainstem gliomas. IEEE Trans Biomed Eng. 2018;65:1943–52.PubMed Liu J, Chen F, Pan C, Zhu M, Zhang X, Zhang L, et al. A cascaded deep convolutional neural network for joint segmentation and genotype prediction of brainstem gliomas. IEEE Trans Biomed Eng. 2018;65:1943–52.PubMed
82.
Zurück zum Zitat Bilgin C, Demir C, Nagi C, Yener B. Cell-graph mining for breast tissue modeling and classification. In: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2007. p. 5311–4. Bilgin C, Demir C, Nagi C, Yener B. Cell-graph mining for breast tissue modeling and classification. In: 2007 29th Annual International Conference of the IEEE Engineering in Medicine and Biology Society. 2007. p. 5311–4.
83.
Zurück zum Zitat Sertel O, Kong J, Catalyurek UV, Lozanski G, Saltz JH, Gurcan MN. Histopathological image analysis using model-based intermediate representations and color texture: follicular lymphoma grading. J Sign Process Syst Sign Image Video Technol. 2008;55:169. Sertel O, Kong J, Catalyurek UV, Lozanski G, Saltz JH, Gurcan MN. Histopathological image analysis using model-based intermediate representations and color texture: follicular lymphoma grading. J Sign Process Syst Sign Image Video Technol. 2008;55:169.
84.
Zurück zum Zitat Gurcan MN, Boucheron LE, Can A, Madabhushi A, Rajpoot NM, Yener B. Histopathological image analysis: a review. IEEE Rev Biomed Eng. 2009;2:147–71.PubMedPubMedCentral Gurcan MN, Boucheron LE, Can A, Madabhushi A, Rajpoot NM, Yener B. Histopathological image analysis: a review. IEEE Rev Biomed Eng. 2009;2:147–71.PubMedPubMedCentral
85.
Zurück zum Zitat Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol. 2004;35:1179–88.PubMed Marchevsky AM, Wick MR. Evidence-based medicine, medical decision analysis, and pathology. Hum Pathol. 2004;35:1179–88.PubMed
86.
Zurück zum Zitat Rodenacker K, Bengtsson E. A feature set for cytometry on digitized microscopic images. Anal Cell Pathol. 2003;25:1–36.PubMedPubMedCentral Rodenacker K, Bengtsson E. A feature set for cytometry on digitized microscopic images. Anal Cell Pathol. 2003;25:1–36.PubMedPubMedCentral
87.
Zurück zum Zitat Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology. Nat Rev Clin Oncol. 2019;16:703–15.PubMedPubMedCentral Bera K, Schalper KA, Rimm DL, Velcheti V, Madabhushi A. Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology. Nat Rev Clin Oncol. 2019;16:703–15.PubMedPubMedCentral
89.
Zurück zum Zitat Fukuma K, Prasath VBS, Kawanaka H, Aronow BJ, Takase H. A study on nuclei segmentation, feature extraction and disease stage classification for human brain histopathological images. Proc Comput Sci. 2016;96:1202–10. Fukuma K, Prasath VBS, Kawanaka H, Aronow BJ, Takase H. A study on nuclei segmentation, feature extraction and disease stage classification for human brain histopathological images. Proc Comput Sci. 2016;96:1202–10.
90.
Zurück zum Zitat Wang X, Wang D, Yao Z, Xin B, Wang B, Lan C, et al. Machine learning models for multiparametric glioma grading with quantitative result interpretations. Front Neurosci. 2019;11:1046. Wang X, Wang D, Yao Z, Xin B, Wang B, Lan C, et al. Machine learning models for multiparametric glioma grading with quantitative result interpretations. Front Neurosci. 2019;11:1046.
91.
Zurück zum Zitat Yonekura A, Kawanaka H, Prasath VBS, Aronow BJ, Takase H. Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network. Biomed Eng Lett. 2018;8:321–7.PubMedPubMedCentral Yonekura A, Kawanaka H, Prasath VBS, Aronow BJ, Takase H. Automatic disease stage classification of glioblastoma multiforme histopathological images using deep convolutional neural network. Biomed Eng Lett. 2018;8:321–7.PubMedPubMedCentral
92.
Zurück zum Zitat Ker J, Bai Y, Lee HY, Rao J, Wang L. Automated brain histology classification using machine learning. J Clin Neurosci. 2019;66:239–45.PubMed Ker J, Bai Y, Lee HY, Rao J, Wang L. Automated brain histology classification using machine learning. J Clin Neurosci. 2019;66:239–45.PubMed
93.
Zurück zum Zitat Gordillo N, Montseny E, Sobrevilla P. State of the art survey on MRI brain tumor segmentation. Magn Reson Imaging. 2013;31:1426–38.PubMed Gordillo N, Montseny E, Sobrevilla P. State of the art survey on MRI brain tumor segmentation. Magn Reson Imaging. 2013;31:1426–38.PubMed
94.
Zurück zum Zitat LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature. 2015;521:436–44.
95.
Zurück zum Zitat Litjens G, Kooi T, Bejnordi BE, Setio AAA, Ciompi F, Ghafoorian M, et al. A survey on deep learning in medical image analysis. Med Image Anal. 2017;42:60–88.PubMed Litjens G, Kooi T, Bejnordi BE, Setio AAA, Ciompi F, Ghafoorian M, et al. A survey on deep learning in medical image analysis. Med Image Anal. 2017;42:60–88.PubMed
96.
Zurück zum Zitat Lotan E, Jain R, Razavian N, Fatterpekar GM, Lui YW. State of the art: machine learning applications in glioma imaging. Am J Roentgenol. 2018;212:26–37. Lotan E, Jain R, Razavian N, Fatterpekar GM, Lui YW. State of the art: machine learning applications in glioma imaging. Am J Roentgenol. 2018;212:26–37.
97.
Zurück zum Zitat Tustison NJ, Shrinidhi KL, Wintermark M, Durst CR, Kandel BM, Gee JC, et al. Optimal symmetric multimodal templates and concatenated random forests for supervised brain tumor segmentation (simplified) with ANTsR. Neuroinformatics. 2015;13:209–25.PubMed Tustison NJ, Shrinidhi KL, Wintermark M, Durst CR, Kandel BM, Gee JC, et al. Optimal symmetric multimodal templates and concatenated random forests for supervised brain tumor segmentation (simplified) with ANTsR. Neuroinformatics. 2015;13:209–25.PubMed
98.
Zurück zum Zitat Pereira S, Pinto A, Alves V, Silva CA. Brain tumor segmentation using convolutional neural networks in MRI images. IEEE Trans Med Imaging. 2016;35:1240–51.PubMed Pereira S, Pinto A, Alves V, Silva CA. Brain tumor segmentation using convolutional neural networks in MRI images. IEEE Trans Med Imaging. 2016;35:1240–51.PubMed
99.
Zurück zum Zitat Havaei M, Davy A, Warde-Farley D, Biard A, Courville A, Bengio Y, et al. Brain tumor segmentation with deep neural networks. Med Image Anal. 2017;35:18–31.PubMed Havaei M, Davy A, Warde-Farley D, Biard A, Courville A, Bengio Y, et al. Brain tumor segmentation with deep neural networks. Med Image Anal. 2017;35:18–31.PubMed
100.
Zurück zum Zitat Kamnitsas K, Ledig C, Newcombe VFJ, Simpson JP, Kane AD, Menon DK, et al. Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal. 2017;36:61–78.PubMed Kamnitsas K, Ledig C, Newcombe VFJ, Simpson JP, Kane AD, Menon DK, et al. Efficient multi-scale 3D CNN with fully connected CRF for accurate brain lesion segmentation. Med Image Anal. 2017;36:61–78.PubMed
101.
Zurück zum Zitat Cui S, Mao L, Jiang J, Liu C, Xiong S. Automatic semantic segmentation of brain gliomas from MRI images using a deep cascaded neural network. J Healthc Eng. 2018;2018:4940593.PubMedPubMedCentral Cui S, Mao L, Jiang J, Liu C, Xiong S. Automatic semantic segmentation of brain gliomas from MRI images using a deep cascaded neural network. J Healthc Eng. 2018;2018:4940593.PubMedPubMedCentral
102.
Zurück zum Zitat Blanc-Durand P, Gucht AVD, Schaefer N, Itti E, Prior JO. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: a full 3D U-Net convolutional neural network study. PLoS ONE. 2018;13:e0195798.PubMedPubMedCentral Blanc-Durand P, Gucht AVD, Schaefer N, Itti E, Prior JO. Automatic lesion detection and segmentation of 18F-FET PET in gliomas: a full 3D U-Net convolutional neural network study. PLoS ONE. 2018;13:e0195798.PubMedPubMedCentral
103.
Zurück zum Zitat Li Z, Wang Y, Yu J, Shi Z, Guo Y, Chen L, et al. Low-grade glioma segmentation based on CNN with fully connected CRF. J Healthc Eng. 2017;2017:9283480.PubMedPubMedCentral Li Z, Wang Y, Yu J, Shi Z, Guo Y, Chen L, et al. Low-grade glioma segmentation based on CNN with fully connected CRF. J Healthc Eng. 2017;2017:9283480.PubMedPubMedCentral
105.
Zurück zum Zitat Sengupta A, Agarwal S, Gupta PK, Ahlawat S, Patir R, Gupta RK, et al. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images. Eur J Radiol. 2018;106:199–208.PubMed Sengupta A, Agarwal S, Gupta PK, Ahlawat S, Patir R, Gupta RK, et al. On differentiation between vasogenic edema and non-enhancing tumor in high-grade glioma patients using a support vector machine classifier based upon pre and post-surgery MRI images. Eur J Radiol. 2018;106:199–208.PubMed
106.
Zurück zum Zitat Bonte S, Goethals I, Van Holen R. Machine learning based brain tumour segmentation on limited data using local texture and abnormality. Comput Biol Med. 2018;98:39–47.PubMed Bonte S, Goethals I, Van Holen R. Machine learning based brain tumour segmentation on limited data using local texture and abnormality. Comput Biol Med. 2018;98:39–47.PubMed
107.
Zurück zum Zitat Garzon-Muvdi T, Kut C, Li X, Chaichana KL. Intraoperative imaging techniques for glioma surgery. Future Oncol. 2017;13:1731–45.PubMedPubMedCentral Garzon-Muvdi T, Kut C, Li X, Chaichana KL. Intraoperative imaging techniques for glioma surgery. Future Oncol. 2017;13:1731–45.PubMedPubMedCentral
108.
Zurück zum Zitat Fabelo H, Halicek M, Ortega S, Shahedi M, Szolna A, Piñeiro JF, et al. Deep learning-based framework for in vivo identification of glioblastoma tumor using hyperspectral images of human brain. Sensors. 2019;19:920. Fabelo H, Halicek M, Ortega S, Shahedi M, Szolna A, Piñeiro JF, et al. Deep learning-based framework for in vivo identification of glioblastoma tumor using hyperspectral images of human brain. Sensors. 2019;19:920.
109.
Zurück zum Zitat Zhang H, Wang R, Yu Y, Liu J, Luo T, Fan F. Glioblastoma treatment modalities besides surgery. J Cancer. 2019;10:4793–806.PubMedPubMedCentral Zhang H, Wang R, Yu Y, Liu J, Luo T, Fan F. Glioblastoma treatment modalities besides surgery. J Cancer. 2019;10:4793–806.PubMedPubMedCentral
110.
Zurück zum Zitat Daisne J-F, Blumhofer A. Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation. Radiat Oncol. 2013;8:154.PubMedPubMedCentral Daisne J-F, Blumhofer A. Atlas-based automatic segmentation of head and neck organs at risk and nodal target volumes: a clinical validation. Radiat Oncol. 2013;8:154.PubMedPubMedCentral
111.
Zurück zum Zitat Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI. Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging. 2018;2018:6828396.PubMedPubMedCentral Zikou A, Sioka C, Alexiou GA, Fotopoulos A, Voulgaris S, Argyropoulou MI. Radiation necrosis, pseudoprogression, pseudoresponse, and tumor recurrence: imaging challenges for the evaluation of treated gliomas. Contrast Media Mol Imaging. 2018;2018:6828396.PubMedPubMedCentral
112.
Zurück zum Zitat Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging. 2018;9:1057–75.PubMedPubMedCentral Kessler AT, Bhatt AA. Brain tumour post-treatment imaging and treatment-related complications. Insights Imaging. 2018;9:1057–75.PubMedPubMedCentral
113.
Zurück zum Zitat Hu X, Wong KK, Young GS, Guo L, Wong ST. Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging. 2011;33:296–305.PubMedPubMedCentral Hu X, Wong KK, Young GS, Guo L, Wong ST. Support vector machine multiparametric MRI identification of pseudoprogression from tumor recurrence in patients with resected glioblastoma. J Magn Reson Imaging. 2011;33:296–305.PubMedPubMedCentral
114.
Zurück zum Zitat Jang B-S, Jeon SH, Kim IH, Kim IA. Prediction of pseudoprogression versus progression using machine learning algorithm in glioblastoma. Sci Rep. 2018;8:12516.PubMedPubMedCentral Jang B-S, Jeon SH, Kim IH, Kim IA. Prediction of pseudoprogression versus progression using machine learning algorithm in glioblastoma. Sci Rep. 2018;8:12516.PubMedPubMedCentral
115.
Zurück zum Zitat Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2014;13:8–17.PubMedPubMedCentral Kourou K, Exarchos TP, Exarchos KP, Karamouzis MV, Fotiadis DI. Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J. 2014;13:8–17.PubMedPubMedCentral
116.
Zurück zum Zitat Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, et al. A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep. 2017;7:10353.PubMedPubMedCentral Lao J, Chen Y, Li Z-C, Li Q, Zhang J, Liu J, et al. A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme. Sci Rep. 2017;7:10353.PubMedPubMedCentral
117.
Zurück zum Zitat Nie D, Lu J, Zhang H, Adeli E, Wang J, Yu Z, et al. Multi-channel 3D deep feature learning for survival time prediction of brain tumor patients using multi-modal neuroimages. Sci Rep. 2019;9:1103.PubMedPubMedCentral Nie D, Lu J, Zhang H, Adeli E, Wang J, Yu Z, et al. Multi-channel 3D deep feature learning for survival time prediction of brain tumor patients using multi-modal neuroimages. Sci Rep. 2019;9:1103.PubMedPubMedCentral
118.
Zurück zum Zitat Sarkiss CA, Germano IM. Machine learning in neuro-oncology: can data analysis from 5346 patients change decision-making paradigms? World Neurosurg. 2019;124:287–94. Sarkiss CA, Germano IM. Machine learning in neuro-oncology: can data analysis from 5346 patients change decision-making paradigms? World Neurosurg. 2019;124:287–94.
119.
Zurück zum Zitat Calabrese E, Villanueva-Meyer JE, Cha S. A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas. Sci Rep. 2020;10:11852.PubMedPubMedCentral Calabrese E, Villanueva-Meyer JE, Cha S. A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas. Sci Rep. 2020;10:11852.PubMedPubMedCentral
120.
Zurück zum Zitat Veronese E, Castellani U, Peruzzo D, Bellani M, Brambilla P. Machine learning approaches: from theory to application in schizophrenia. Comput Math Methods Med. 2013;2013:867924.PubMedPubMedCentral Veronese E, Castellani U, Peruzzo D, Bellani M, Brambilla P. Machine learning approaches: from theory to application in schizophrenia. Comput Math Methods Med. 2013;2013:867924.PubMedPubMedCentral
121.
Zurück zum Zitat Mehdy MM, Ng PY, Shair EF, Saleh NIM, Gomes C. Artificial neural networks in image processing for early detection of breast cancer. Comput Math Methods Med. 2017;2017:2610628.PubMedPubMedCentral Mehdy MM, Ng PY, Shair EF, Saleh NIM, Gomes C. Artificial neural networks in image processing for early detection of breast cancer. Comput Math Methods Med. 2017;2017:2610628.PubMedPubMedCentral
Metadaten
Titel
Can artificial intelligence overtake human intelligence on the bumpy road towards glioma therapy?
verfasst von
Precilla S Daisy
T. S. Anitha
Publikationsdatum
01.05.2021
Verlag
Springer US
Erschienen in
Medical Oncology / Ausgabe 5/2021
Print ISSN: 1357-0560
Elektronische ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-021-01500-2

Weitere Artikel der Ausgabe 5/2021

Medical Oncology 5/2021 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.